Lupin (LUPIN) — Financial Results

Lupin Limited reported Q1 FY26 revenue of ₹6,164 crores, growing 11.8% YoY with EBITDA surging 27.6% YoY to ₹1,641 crores. EBITDA margins expanded 330 basis points to 26.6%, while gross margins improved to 71.3%. The U.S. Tolvaptan launch achieved highest U.S. revenues since Q4 FY2017. India formulations grew 8.6% YoY and Other Developed Markets grew 17% YoY. Management reaffirmed FY26 EBITDA margin guidance of 24-25% and R&D spending of 7.5-8.5% of sales, with upcoming launches of Glucagon, Liraglutide (October 2025), and Risperdal Consta (September 2025).

📄 View Original Announcement (PDF)

📊 Stock Analysis — LUPIN ✨ Ask AI About This

About Lupin Limited (LUPIN)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹1,04,071.47 Cr P/E: 36.2

View full LUPIN stock details →

📡 Get AI alerts when LUPIN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track LUPIN — Free

💡 Ask AI about this filing

"How does this financial results affect Lupin Limited's outlook?" "What did Lupin Limited announce on 11 August 2025?" "Is this positive or negative for LUPIN?"

Ask AI Free →

📊 More LUPIN filings

See all LUPIN filings →

🔥 Also filed on 11 August 2025

SHRIRAMFIN Shriram Finance Limited Corporate Action TATAPOWER Tata Power Company Limited Announcement TITAN Titan Company Limited Financial Results TRENT Trent Limited Financial Results BHARTIARTL Bharti Airtel Limited Financial Results SBIN State Bank of India Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when LUPIN files new disclosures

Track LUPIN filings, board meetings, and corporate actions. Free email alerts at 5 PM.